Magnetic Resonance-Guided Radiotherapy Using an Integrated Magnetic Resonance Linear Accelerator (MRL)
Summary
Advances in radiotherapy are closely tied to imaging technology, with a new system combining a 1.5T MRI and a linear accelerator (MR-LINAC) now available. This system, used in a few centers worldwide, offers better soft tissue imaging and daily adjustments for more accurate treatment. The Calgary Cancer Centre, set to open in late 2024, will be the only cancer center in Canada with two MR-LINAC machines, potentially improving cancer control and reducing side effects. However, it is complex and resource-intensive, requiring specialized training. The system enables daily adaptive treatments based on MRI scans, better targeting tumors while protecting surrounding organs. Over time, increased experience and automation are expected to streamline these processes. The primary goal is to understand where MR-LINAC improves outcomes and develop efficient, cost-effective treatments.
Eligibility
Eligible ages: 18 to 120
Accepts healthy participants: Yes
Inclusion criteria:
- Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
- Planned to receive a course of MR-guided adaptive radiotherapy using the MR-LINAC
- Ability to provide informed consent
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Sangjune Laurence Lee, MD, FRCPC Division of Radiation Oncology, University of Calgary, Arthur J.E. Child Comprehensive Cancer Centre (CCC) 3395 Hospital Dr NW, Calgary, AB T2N 4N1 Ph: 403-521-3164, Fax: 403-283-1651
Principal investigator:
Sangjune Lee
Clinical trial:
No
REB-ID:
HREBA.CC-24-0311